1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Graft-versus-host-disease: new trials by email Literature Review of Graft-versus-host-disease trials Research Report on Graft-versus-host-disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD Prophylaxis Treatment Arm - high dose ATG, Control Arm - standard of care - Graft-versus-host-disease, Relapse | Phase 2 | Terminated | AHS Cancer Control Alberta | 68 | 2020-07-01 | 2025-07-18 |
Graft vs Host Disease (1) · Recurrence (1)
Disease Attributes (1) · Immune System Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
AHS Cancer Control Alberta (1)
Canada (1)
Jan Storek, MD (1)